106 related articles for article (PubMed ID: 27017408)
1. Nitric oxide and reactive oxygen species: Clues to target oxidative damage repair defective breast cancers.
Somasundaram V; Nadhan R; K Hemalatha S; Kumar Sengodan S; Srinivas P
Crit Rev Oncol Hematol; 2016 May; 101():184-92. PubMed ID: 27017408
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide and interactions with reactive oxygen species in the development of melanoma, breast, and colon cancer: A redox signaling perspective.
Monteiro HP; Rodrigues EG; Amorim Reis AKC; Longo LS; Ogata FT; Moretti AIS; da Costa PE; Teodoro ACS; Toledo MS; Stern A
Nitric Oxide; 2019 Aug; 89():1-13. PubMed ID: 31009708
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide plays a dual role in the oxidative injury of cultured rat microglia but not astroglia.
Wang JY; Lee CT; Wang JY
Neuroscience; 2014 Dec; 281():164-77. PubMed ID: 25280787
[TBL] [Abstract][Full Text] [Related]
4. Nitroxide antioxidant as a potential strategy to attenuate the oxidative/nitrosative stress induced by hydrogen peroxide plus nitric oxide in cultured neurons.
Lee CT; Yu LE; Wang JY
Nitric Oxide; 2016 Apr; 54():38-50. PubMed ID: 26891889
[TBL] [Abstract][Full Text] [Related]
5. Involvement of xanthine oxidase activity with oxidative and inflammatory renal damage in silver catfish experimentally infected with Streptococcus agalactiae: Interplay with reactive oxygen species and nitric oxide.
Souza CF; Baldissera MD; Moreira KLS; da Rocha MIUM; da Veiga ML; Santos RCV; Baldisserotto B
Microb Pathog; 2017 Oct; 111():1-5. PubMed ID: 28804017
[TBL] [Abstract][Full Text] [Related]
6. [Beta-glucan as a natural anticancer agent].
Jurczyńska E; Saczko J; Kulbacka J; Kawa-Rygielska J; Błazewicz J
Pol Merkur Lekarski; 2012 Oct; 33(196):217-20. PubMed ID: 23272610
[TBL] [Abstract][Full Text] [Related]
7. Reactive oxygen species in redox cancer therapy.
Tong L; Chuang CC; Wu S; Zuo L
Cancer Lett; 2015 Oct; 367(1):18-25. PubMed ID: 26187782
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial reactive oxygen species and nitric oxide-mediated cancer cell apoptosis in 2-butylamino-2-demethoxyhypocrellin B photodynamic treatment.
Lu Z; Tao Y; Zhou Z; Zhang J; Li C; Ou L; Zhao B
Free Radic Biol Med; 2006 Nov; 41(10):1590-605. PubMed ID: 17045927
[TBL] [Abstract][Full Text] [Related]
9. Different kinds of reactive oxygen and nitrogen species were detected in colon and breast tumors.
Haklar G; Sayin-Ozveri E; Yüksel M; Aktan AO; Yalçin AS
Cancer Lett; 2001 Apr; 165(2):219-24. PubMed ID: 11275372
[TBL] [Abstract][Full Text] [Related]
10. Silibinin induces the generation of nitric oxide in human breast cancer MCF-7 cells.
Wang HJ; Wei XF; Jiang YY; Huang H; Yang Y; Fan SM; Zang LH; Tashiro S; Onodera S; Ikejima T
Free Radic Res; 2010 May; 44(5):577-84. PubMed ID: 20370556
[TBL] [Abstract][Full Text] [Related]
11. A reactive oxygen species activation mechanism contributes to JS-K-induced apoptosis in human bladder cancer cells.
Qiu M; Chen L; Tan G; Ke L; Zhang S; Chen H; Liu J
Sci Rep; 2015 Oct; 5():15104. PubMed ID: 26458509
[TBL] [Abstract][Full Text] [Related]
12. Induction of a feed forward pro-apoptotic mechanistic loop by nitric oxide in a human breast cancer model.
Sen S; Kawahara B; Fukuto J; Chaudhuri G
PLoS One; 2013; 8(8):e70593. PubMed ID: 23950968
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer.
Brown NS; Bicknell R
Breast Cancer Res; 2001; 3(5):323-7. PubMed ID: 11597322
[TBL] [Abstract][Full Text] [Related]
14. [Reactive nitrogen and oxygen species metabolism in rat heart mitochondria upon administration of NO donor in vivo].
Akopova OV; Korkach IuP; Kotsiuruba AV; Kolchyns'ka LI; Sagach VF
Fiziol Zh (1994); 2012; 58(2):3-15. PubMed ID: 22873047
[TBL] [Abstract][Full Text] [Related]
15. Proanthocyanidin protects against cisplatin-induced oxidative liver damage through inhibition of inflammation and NF-κβ/TLR-4 pathway.
El-Shitany NA; Eid B
Environ Toxicol; 2017 Jul; 32(7):1952-1963. PubMed ID: 28371137
[TBL] [Abstract][Full Text] [Related]
16. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
[TBL] [Abstract][Full Text] [Related]
17. The Role of Oxidative Stress Modulators in Breast Cancer.
Gurer-Orhan H; Ince E; Konyar D; Saso L; Suzen S
Curr Med Chem; 2018; 25(33):4084-4101. PubMed ID: 28699501
[TBL] [Abstract][Full Text] [Related]
18. Novel anticancer hybrids from diazen-1-ium-1,2-diolate nitric oxide donor and ROS inducer plumbagin: Design, synthesis and biological evaluations.
Bao N; Ou J; Li N; Zou P; Sun J; Chen L
Eur J Med Chem; 2018 Jun; 154():1-8. PubMed ID: 29772386
[TBL] [Abstract][Full Text] [Related]
19. Reactive oxygen species-mediated synergistic and preferential induction of cell death and reduction of clonogenic resistance in breast cancer cells by combined cisplatin and FK228.
Pluchino LA; Choudhary S; Wang HC
Cancer Lett; 2016 Oct; 381(1):124-32. PubMed ID: 27477899
[TBL] [Abstract][Full Text] [Related]
20. The role of oxidative stress on breast cancer development and therapy.
Hecht F; Pessoa CF; Gentile LB; Rosenthal D; Carvalho DP; Fortunato RS
Tumour Biol; 2016 Apr; 37(4):4281-91. PubMed ID: 26815507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]